Patents
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
10/1993
10/28/1993WO1993021317A1 ISOLATION, CHARACTERIZATION, AND USE OF THE HUMAN β SUBUNIT OF THE HIGH AFFINITY RECEPTOR FOR IMMUNOGLOBULIN E
10/28/1993WO1993021316A1 Mammalian melanocyte stimulating hormone receptors and uses
10/28/1993WO1993021314A1 Peptides having a gdp exchange factor activity, nucleic acid sequences coding for said peptides, preparation and utilization
10/28/1993WO1993021302A1 Cadherin materials and methods
10/28/1993WO1993021232A1 IMMUNOTOXINS DIRECTED AGAINST c-erbB-2 (HER-2/neu) RELATED SURFACE ANTIGENS
10/28/1993WO1993021231A1 Adh water channel altering composition
10/28/1993WO1993021230A1 Activation-state-specific phosphoprotein immunodetection
10/28/1993WO1993020935A1 Activated substrate materials, their production and use
10/28/1993WO1993020852A2 Macrocyclic chelating agents, chelates and conjugates thereof
10/28/1993WO1993020848A1 Immunotoxins directed against cd33 related surface antigens
10/28/1993WO1993020843A1 Oral treatment of helicobacter infection
10/28/1993WO1993020841A1 Antibodies specific for carcinoma-associated antigens
10/28/1993WO1993020839A2 Use of renin-angiotensin antagonist for reducing post myocardial infarct mobidity and mortality
10/28/1993WO1993020830A1 Monocyte adhesion protein and monoclonal antibody thereto
10/28/1993WO1993017115A3 Dysentery vaccine stimulating an immune response against shigatoxin, plasmids and host strains for it
10/28/1993WO1993014206A3 Synthetic peptides for a rubella vaccine
10/28/1993DE4213497A1 New human interferon gamma (HIFNG) monoclonal antibodies - produced by immunising mice with spleen cells from mice having high serum antibody titre for HIFNG, followed by immobilised HIFNG
10/28/1993CA2388198A1 Adrenocorticotropic hormone receptor and uses
10/28/1993CA2133739A1 Immunotoxins directed against c-erbb-2 (her-2/neu) related surface antigens
10/28/1993CA2133339A1 Wild-type measles virus glycoproteins: vaccine and detection method therefor
10/28/1993CA2131166A1 Peptides having a gdp exchange factor activity, nucleic acid sequences coding for said peptides, preparation and utilization
10/28/1993CA2117775A1 Process for preparing macrocyclic chelating agents and formation of chelates and conjugates thereof
10/28/1993CA2111189A1 Oral treatment of helicobacter infection
10/27/1993EP0566698A1 Amino-substituted pyrimidines, derivatives and methods of use therefor
10/27/1993EP0566647A1 Improved humanized immunoglobulins
10/27/1993EP0566611A1 Analogs of piscine lhrh
10/26/1993US5256771 Heat treatment of IgM-containing immunoglobulins to eliminate non-specific complement activation
10/26/1993US5256766 Recombinant thrombin receptor and related pharmaceuticals
10/26/1993US5256643 For diagnosis of colorectal and breast cancers
10/26/1993US5256642 Compositions of soluble complement receptor 1 (CR1) and a thrombolytic agent, and the methods of use thereof
10/26/1993US5256561 Monoclonal antibody to HIV-2 and uses thereof
10/26/1993US5256560 Suspension of mammalian, non-murine, non-human cells comprised of pluripotent lymphohematopoietic non-adherent progenitor stem cells which produce primitive cell colony stimulating factors
10/26/1993US5256558 Gene encoding plant asparagine synthetase
10/26/1993US5256538 Detection of early platelet activation and prediagnosis of thrombotic events
10/26/1993US5256536 Hybridization
10/26/1993US5256412 Plasma protein modified to negative moiety
10/26/1993US5256411 Immune cell proliferation inhibitors
10/26/1993US5256409 Complexing two drug haptens to carrier protein
10/26/1993US5256395 Drug delivery by administering a receptor binding assay having a dual preferential monoclonal antibody conjugating with predetermined haptens
10/26/1993CA1323728C Human gamma interferon-specific receptor protein, antibody against said protein, methods for obtaining said protein and said antibody and compositions containing said protein and antibody
10/26/1993CA1323567C Method for purification of antibodies
10/21/1993CA2093735A1 Amyloid precursor-like protein and uses thereof
10/20/1993EP0566205A1 Method for the elimination of non-specific reactions in immuno-assays
10/20/1993EP0566066A1 Antigens of human non-small lung carcinoma
10/20/1993EP0565978A1 Artivated carriers, their fabrication and use
10/20/1993EP0565642A1 Method of preventing inflammatory damage
10/20/1993EP0529065A4 Receptor-based screening methods for amylin agonists and antagonists
10/19/1993US5254799 Transformation vectors allowing expression of Bacillus thuringiensis endotoxins in plants
10/19/1993US5254672 Synthetic peptides which contain sequences from factor VIIa, and the use thereof
10/19/1993US5254671 Extracellular segments of human e immunoglobulin anchoring peptides and antibodies specific therefor
10/19/1993US5254593 Compositions containing biguanides and derivatives thereof as inhibitors of nonenzymatic cross-linking
10/19/1993US5254532 Preparation for treating and preventing thromboses and thromboembolic complications, use of such a preparation and a method of producing the same
10/19/1993US5254457 Monoclonal antibodies and method for identifying different aids-related viruses
10/18/1993CA2093494A1 Method for the elimination of non-specific reactions in immuno-assays
10/15/1993CA2093866A1 Methods of inhibiting the growth of multidrug resistant tumors
10/14/1993WO1993020442A1 Reagents and methods for the detection and quantification of thyroxine in fluid samples
10/14/1993WO1993020439A1 Compositions and methods for regulating cellular signal transducing systems
10/14/1993WO1993020238A2 Amplification of human mdm2 gene in human tumors
10/14/1993WO1993020229A1 ANTIBODIES TO ALPHAvBETA3 INTEGRIN
10/14/1993WO1993020210A1 Antibodies for treatment and prevention of respiratory syncytial virus infection
10/14/1993WO1993020205A1 ANTI-HBs ANTIBODY GENE AND EXPRESSION PLASMID THEREOF
10/14/1993WO1993020199A1 Human gonadotropin receptor (fsh receptor)
10/14/1993WO1993020197A1 Stem cell proliferation factor
10/14/1993WO1993020189A1 Process for the production of a viable cell culture infected by a multiple sclerosis associated virus
10/14/1993WO1993020188A1 Process and culture medium for the production of cells infected by a multiple sclerosis associated virus
10/14/1993WO1993020187A1 Monoclonal antibodies against the interferon receptor, with neutralizing activity against type i interferon
10/14/1993WO1993020104A1 Monoclonal antibodies against a carbohydrate-dependent epitope related to the v2 region of hiv-1 gp120
10/14/1993WO1993020079A1 Novel opiate derivatives and protein and polypeptide opiate derivative conjugates and labels
10/14/1993WO1993020076A1 Catalytic antibodies against cocaine and methods of using and producing same
10/14/1993WO1993020070A1 Novel tetrahydrocannabinol derivatives and protein and polypeptide tetrahydrocannabinol derivative conjugates and labels
10/14/1993WO1993020067A1 Benzodiazepine derivatives and protein and polypeptide conjugates thereof
10/14/1993WO1993020064A1 Novel barbiturate derivatives and protein and polypeptide barbiturate derivative conjugates and labels
10/14/1993WO1993020060A1 5(6)-methyl substituted fluorescein derivatives
10/14/1993WO1993020049A1 Novel phencyclidine derivatives and protein and polypeptide phencyclidine derivative conjugates and labels
10/14/1993WO1993020048A1 Novel amphetamine derivatives and protein and polypeptide amphetamine derivative conjugates and labels
10/14/1993WO1993019786A1 High affinity, strongly neutralizing monoclonal antibodies against the cd-4 binding site of gp120 of human immunodeficiency virus
10/14/1993WO1993019785A1 Recombinant human hiv-neutralizing monoclonal antibodies for prevention and treatment of hiv infection
10/14/1993WO1993019784A1 Novel endothelial adhesion molecule for monocytes
10/14/1993WO1993019783A1 Methods of inhibiting or enhancing scar formation in the cns
10/14/1993WO1993019782A1 Specific detection of cell surface receptor leukocyte adhesion molecule-1
10/14/1993WO1993019767A1 Cd28 pathway immunoregulation
10/14/1993WO1993019761A1 Lipid-a analogs: new monosaccharide and disaccharide intermediates for eliciting therapeutic antibodies and for antitumor and antiviral activities
10/14/1993WO1993019668A1 Method and kit for imaging and treating organs and tissues
10/14/1993WO1993019605A1 Evaluation and treatment of patients with progressive immunosuppression
10/14/1993WO1993014208A3 Hepatitis e virus vaccine and method
10/14/1993CA2133662A1 Antibodies for treatment and prevention of respiratory syncytial virus infection
10/14/1993CA2133075A1 CD28 Pathway Immunoregulation
10/14/1993CA2132624A1 Compositions and methods for regulating cellular signal transducing systems
10/14/1993CA2132446A1 Novel barbiturate derivatives and protein and polypeptide barbiturate derivative conjugates and labels
10/14/1993CA2132445A1 Novel tetrahydrocannabinol derivatives and protein and polypeptide tetrahydrocannabinol derivative conjugates and labels
10/14/1993CA2132342A1 Novel opiate derivatives and protein and polypeptide opiate derivative conjugates and labels
10/14/1993CA2132341A1 Benzodiazepine derivatives and protein and polypeptide conjugates thereof
10/14/1993CA2132340A1 Novel amphetamine derivatives and protein and polypeptide amphetamine derivatives conjugates and labels
10/14/1993CA2132339A1 Novel phencyclidine derivatives and protein and polypeptide phencyclidine derivative conjugates and labels
10/14/1993CA2131727A1 Reagents and methods for the detection and quantification of thyroxine in fluid samples
10/14/1993CA2130197A1 5(6)-methyl substituted fluorescein derivatives
10/14/1993CA2126341A1 Lipid-a analogs: new monosaccharide and dissaccharide intermediates for eliciting therapeutic antibodies and for antitumor and antiviral activities
10/14/1993CA2110295A1 Anti-hbs antibody genes and expression plasmids therefor
10/13/1993EP0565208A1 DNA fragment encoding OspA of Borrelia burgdorferi, vaccine and diagnostics comprising OspA encoded by the DNA fragment
10/13/1993EP0564592A1 Liver enriched transcription factor